LIVN Stock Recent News

LivaNova PLC (NASDAQ:LIVN ) Q1 2023 Earnings Conference Call May 3, 2023 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President of Corporate Development William Kozy - Chairman & Interim Chief Executive Officer Alex Shvartsburg - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Financial Michael Polark - Wolfe Research Matthew Taylor - Jefferies Adam Maeder - Piper Sandler Mike Matson - Needham & Company Operator Good day ladies and gentlemen and welcome to the LivaNova PLC First Quarter of 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.

LivaNova (LIVN) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.48 per share a year ago.

LivaNova (LIVN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

After losing some value lately, a hammer chart pattern has been formed for LivaNova (LIVN), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

LivaNova (LIVN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

LivaNova (LIVN) delivered earnings and revenue surprises of 12.50% and 4.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

LivaNova provides high-tech medical devices for the benefit of healthcare professionals, patients, and healthcare systems around the world. Considering the geographic diversification of the business model, LivaNova's revenue model appears to be more solid than that of competitors that operate only in one market.

LONDON--( BUSINESS WIRE )--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth-quarter and full-year 2022 results on Wednesday, February 22, 2023 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its fourth-quarter and full-year 2022 results prior to the call.

LivaNova PLC (NASDAQ:LIVN ) Q3 2022 Results Earnings Conference Call November 2, 2022 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President, Corporate Development Damien McDonald - Chief Executive Officer Alex Shvartsburg - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Mike Polark - Wolfe Research Matt Taylor - Jefferies Mike Matson - Needham & Company, LLC Adam Maeder - Piper Sandler Amit Hazan - Goldman Sachs Operator Good day, ladies and gentlemen, and welcome to the LivaNova PLC Third Quarter 2022 Earnings Conference Call. My name is Charlie and I'll be the coordinator for today's call.

LivaNova (LIVN) delivered earnings and revenue surprises of 1.75% and 2.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?